Postępy Dermatologii i Alergologii

Abstract

3/2012 vol. 29

Review paper Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases

Postep Derm Alergol 2012; XXIX, 3: 196–204
[Polish version: Postep Derm Alergol 2012; XXIX, 3: 205–214]
Online publish date: 2012/07/27
View full text
Combinations of topical glucocorticoids (GCs) with other substances are very often used in dermatology. One of the most common combinations is betamethasone dipropionate and salicylic acid. Betamethasone dipropionate is a potent topical glucocorticoid (belonging to class III according to the European classification) which demonstrates anti-inflammatory, anti-proliferative, immunosuppressive and vasoconstrictive properties. Salicylic acid, in turn, has a strong keratolytic and slightly antiseptic action. The use of both components in one formulation provides a significantly better GC penetration through the skin, which is crucial for the treatment of hyperkeratotic lesions.
Share
without publication fees